Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Alternaturals, Inc. (OTC: ANAS).

Full DD Report for ANAS

Recent News from (OTC: ANAS)

Medgen announces the acquisition of popular alternative healthcare company Alternaturals adding an exciting new product line and revenue stream to its arsenal
Medgen announces the acquisition of popular alternative healthcare company Alternaturals adding an exciting new product line and revenue stream to its arsenal
Source: OTC Markets
Date: September, 22 2015 00:00
Alternaturals Responds to Big Box Retailer Demand
Alternaturals Responds to Big Box Retailer Demand
Source: OTC Markets
Date: August, 12 2015 00:00
Alternaturals announces major business offensive starting with the registration of a US Trademark for the highly anticipated MMJ product 5-hour high
Alternaturals announces major business offensive starting with the registration of a US Trademark for the highly anticipated MMJ product 5-hour high
Source: OTC Markets
Date: August, 06 2015 00:00
Alternaturals completes reverse split in preparation for next steps in its business model
Alternaturals completes reverse split in preparation for next steps in its business model
Source: OTC Markets
Date: August, 03 2015 00:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-23N/A0.0023N/AN/A0
2018-04-22N/A0.0023N/AN/A0
2018-04-21N/A0.0023N/AN/A0
2018-04-20N/A0.0023N/AN/A0
2018-04-19N/A0.0023N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-03-219,6679,667100.0000Short
2018-03-0850,000159,02331.4420Cover
2018-02-202,83422,83412.4113Cover
2018-02-0111,00019,00057.8947Short
2018-01-193,0005,00060.0000Short

* Short Mode

Short Analysis provided by Squeeze Report.


About Alternaturals, Inc. (OTC: ANAS)

Logo for Alternaturals, Inc. (OTC: ANAS)

Alternaturals, Inc. manufactures and sells alternative healthcare products including an all natural sleep aids, as well as many natural substitutes for popular prescription drugs. The company also plans to operate as a distribution company to centralize the fragmented alternative health product industries. Find out more on twitter: alternaturals or email: investors alternaturals.com.

 

 

 

Current Management

  • Matthew Briggs / CEO
  • Mark Figula / CTO

Current Share Structure

  • Market Cap: $57,814 - 03/16/2018
  • Authorized: 250,000,000 - 09/30/2015
  • Issue and Outstanding: 22,236,293 - 09/30/2015
  • Float: 10,063,057 - 08/10/2015

 


Recent Filings from (OTC: ANAS)

Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: November, 13 2015
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: September, 10 2015
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: June, 15 2015
Supplemental Information - Supplemental (Amended) Financial Report For Years ending 12/31/2013 - 2012
Filing Type: Supplemental Information - Supplemental (Amended) Financial Report For Years ending 12/31/2013 - 201Filing Source: OTC Markets
Filing Date: June, 15 2015

 

 


Daily Technical Chart for (OTC: ANAS)

Daily Technical Chart for (OTC: ANAS)


Stay tuned for daily updates and more on (OTC: ANAS)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ANAS)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ANAS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of ANAS and does not buy, sell, or trade any shares of ANAS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/

 

 

Release this Report to Investors

Via Email

Via Text

Important

If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us